BETASERC

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey.

Active ingredients

The drug BETASERC contains one active pharmaceutical ingredient (API):

1	Betahistine dihydrochloride UNII 49K58SMZ7U - BETAHISTINE HYDROCHLORIDE
	Betahistine dihydrochloride is a histamine-like drug in which pharmacological activity can be attributed to a specific effects and/or more direct influences on recovery mechanisms the vestibular nuclei. It has weak agonist activity at histamine H1 receptors and moderate antagonist activity at H3 receptors. Betahistine may increase blood flow to the cochlear region as well as to the whole brain.
	Read more about Betahistine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07CA01	Betahistine	N Nervous system → N07 Other nervous system drugs → N07C Antivertigo preparations → N07CA Antivertigo preparations
Discover more medicines within N07CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500214100032517, 500214100032617, 500214100032717
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	2890-MEE-0617, 2958-MEE-0817, H6280713
EE	Ravimiamet	1008436, 1008458, 1115727, 1115738, 1115749, 1620212, 1620223, 1620234, 1620245, 1620256, 1639414, 1639425, 1639436, 1827064, 1861781
FI	Lääkealan turvallisuus- ja kehittämiskeskus	017541, 020144, 038877
FR	Base de données publique des médicaments	62972963
HK	Department of Health Drug Office	37181, 38792, 51514
HR	Agencija za lijekove i medicinske proizvode	HR-H-070232989, HR-H-722180471
LT	Valstybinė vaistų kontrolės tarnyba	1006779, 1010240, 1015627, 1015628, 1015629, 1056093, 1063039, 1068855, 1070559, 1070749, 1072020, 1072624, 1072625, 1075305, 1075306, 1075307, 1075308, 1078434, 1079725, 1079726, 1085824, 1086394, 1086451, 1086738
MT	Medicines Authority	MA1507/02801, MA1507/02802, PI1438/01701A, PI1438/01702A, PI770/10601A, PI770/10602A, PI908/01401A, PI908/01402A
NL	Z-Index G-Standaard, PRK	27413
PL	Rejestru Produktów Leczniczych	100145540, 100193935, 100194538, 100237680, 100254602, 100254654, 100255270, 100255317, 100255398, 100271871, 100279016, 100279022, 100283762, 100289285, 100294524, 100302614, 100306776, 100336168, 100338291, 100345204, 100349774, 100349863, 100377121, 100384635, 100385273, 100386338, 100393090, 100400104, 100406549, 100408910, 100413242, 100414945, 100418541, 100423536, 100423660, 100424381, 100425400, 100435321, 100447815, 100450506, 100452381, 100464682, 100468171
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68647001, W68647002, W68647003, W68647004, W68647005, W68852001, W68852002, W68853001, W68853002, W68853003, W68853004
SG	Health Sciences Authority	11365P, 12235P
TN	Direction de la Pharmacie et du Médicament	9253072
TR	İlaç ve Tıbbi Cihaz Kurumu	8699548014444, 8699820010058, 8699820010126, 8699820010140, 8699820010324, 8699820010331